Apoptosis
Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
- Caspase(102)
- 14.3.3 Proteins(2)
- Apoptosis Inducers(45)
- Bax(7)
- Bcl-2 Family(122)
- Bcl-xL(8)
- c-RET(9)
- IAP(27)
- KEAP1-Nrf2(67)
- MDM2(15)
- p53(128)
- PC-PLC(5)
- PKD(8)
- RasGAP (Ras- P21)(1)
- Survivin(8)
- Thymidylate Synthase(10)
- TNF-α(151)
- Other Apoptosis(900)
- Apoptosis Detection
- Caspase Substrate
- APC(6)
- PD-1/PD-L1 interaction(91)
- ASK1(3)
- PAR4(2)
- RIP kinase(52)
- FKBP(20)
- Pyroptosis(32)
Apoptosis 相关产品(2721)
- GC10069NSC 23766 trihydrochlorideCAS: 1177865-17-6纯度: >99.50% / >99.00%
NSC 23766 trihydrochloride是一种选择性Rac1 GTPase抑制剂,通过特异性阻断Rac1的鸟嘌呤核苷酸交换因子Trio和Tiam1来抑制Rac1的激活,对Rac1的IC₅₀约为50μM。
- GC10077S- (+)-RolipramCAS: 85416-73-5纯度: >99.50%
S- (+)-Rolipram ((+)-Rolipram) 是一种环状 AMP(cAMP) 特异性磷酸二酯酶 4 (PDE4) 抑制剂,IC50 为 1100 nM。
- GC10111RegorafenibCAS: 755037-03-7纯度: >99.00%
Regorafenib是一种具口服活性的多激酶抑制剂,抑制VEGFR1/2/3,PDGFRβ,Kit,RET和Raf-1的IC 50 值分别为13/4.2/46,22,7,1.5和2.5nM。
- GC10195Z-GuggulsteroneCAS: 39025-23-5纯度: >98.00%
Z-Guggulsterone 是阿育吠陀药用植物 Commiphora mukul 的一种成分,在体外和体内抑制血管生成,IC50 值为 1740、1000、220 和 >; 50000 nM 用于糖皮质激素、盐皮质激素、雄激素和法尼醇 X 受体 。
- GC10225Dacomitinib (PF299804, PF299)CAS: 1110813-31-4纯度: >98.00%
A pan-ErbB receptor tyrosine kinase inhibitor
- GC10282PiperlongumineCAS: 20069-09-4纯度: >99.00% / >98.00%
Piperlongumine是从 Piper longum L. 中提取的天然生物碱化合物,具有多种药理活性,包括抗肿瘤、脂质代谢调节、抗血小板聚集和镇痛活性等。
- GC10291SCH 79797 dihydrochlorideCAS: 1216720-69-2纯度: >98.50% / >98.00%
SCH 79797 dihydrochloride是一种高效的、具有选择性的非肽类蛋白酶激活受体 1(PAR1)拮抗剂,其IC 50 值为70nM,Ki值为35nM。
- GC10345Bay 11-7085CAS: 196309-76-9纯度: >99.00%
Bay 11-7085是一种NF-κB活化和IκBα磷酸化的抑制剂,对IκBα的IC 50 值为10μM。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GA21397 | Dolastatin 15 | 123884-00-4 | - | |
A peptide with anticancer activity | ||||
| GA23337 | Oxythiamine . HCl | 614-05-1 | >95.00% | |
A thiamine antimetabolite | ||||
| GC10008 | GSK1070916 | 942918-07-2 | >98.50% | |
A potent inhibitor of Aurora B and C kinases | ||||
| GC10021 | CPI-360 | 1802175-06-9 | >99.00% | |
A selective EZH2 inhibitor | ||||
| GC10022 | SP 141 | 1253491-42-7 | >99.00% | |
An inhibitor of MDM2 | ||||
| GC10033 | Cobimetinib | 934660-93-2 | >99.50% | |
Cobimetinib是一种强效、选择性的MEK1抑制剂,IC 50 值为0.9nM。 | ||||
| GC10040 | Arylquin 1 | 1630743-73-5 | - | |
A Par-4 secretagogue | ||||
| GC10069 | NSC 23766 trihydrochloride | 1177865-17-6 | >99.50% / >99.00% | |
NSC 23766 trihydrochloride是一种选择性Rac1 GTPase抑制剂,通过特异性阻断Rac1的鸟嘌呤核苷酸交换因子Trio和Tiam1来抑制Rac1的激活,对Rac1的IC₅₀约为50μM。 | ||||
| GC10077 | S- (+)-Rolipram | 85416-73-5 | >99.50% | |
S- (+)-Rolipram ((+)-Rolipram) 是一种环状 AMP(cAMP) 特异性磷酸二酯酶 4 (PDE4) 抑制剂,IC50 为 1100 nM。 | ||||
| GC10083 | MPI-0479605 | 1246529-32-7 | >99.00% | |
A potent inhibitor of MPS1 | ||||
| GC10093 | LY2409881 | 946518-60-1 | >98.50% | |
A selective IKK2 inhibitor | ||||
| GC10098 | (S)-10-Hydroxycamptothecin | 19685-09-7 | >99.00% | |
A DNA topoisomerase I inhibitor | ||||
| GC10111 | Regorafenib | 755037-03-7 | >99.00% | |
Regorafenib是一种具口服活性的多激酶抑制剂,抑制VEGFR1/2/3,PDGFRβ,Kit,RET和Raf-1的IC 50 值分别为13/4.2/46,22,7,1.5和2.5nM。 | ||||
| GC10171 | Puromycin aminonucleoside | 58-60-6 | >98.00% | |
A glomerular epithelial cell toxin | ||||
| GC10195 | Z-Guggulsterone | 39025-23-5 | >98.00% | |
Z-Guggulsterone 是阿育吠陀药用植物 Commiphora mukul 的一种成分,在体外和体内抑制血管生成,IC50 值为 1740、1000、220 和 >; 50000 nM 用于糖皮质激素、盐皮质激素、雄激素和法尼醇 X 受体 。 | ||||
| GC10200 | Mdivi 1 | 338967-87-6 | >99.50% / >98.00% | |
Mdivi-1(线粒体分裂抑制剂 1)抑制创伤性脑损伤 (TBI) 诱导的动力蛋白相关蛋白 1 (Drp1) 上调、自噬功能障碍和线粒体自噬激活。 | ||||
| GC10225 | Dacomitinib (PF299804, PF299) | 1110813-31-4 | >98.00% | |
A pan-ErbB receptor tyrosine kinase inhibitor | ||||
| GC10265 | Manumycin A | 52665-74-4 | >98.00% | |
A farnesyltransferase inhibitor with antitumor activity | ||||
| GC10282 | Piperlongumine | 20069-09-4 | >99.00% / >98.00% | |
Piperlongumine是从 Piper longum L. 中提取的天然生物碱化合物,具有多种药理活性,包括抗肿瘤、脂质代谢调节、抗血小板聚集和镇痛活性等。 | ||||
| GC10291 | SCH 79797 dihydrochloride | 1216720-69-2 | >98.50% / >98.00% | |
SCH 79797 dihydrochloride是一种高效的、具有选择性的非肽类蛋白酶激活受体 1(PAR1)拮抗剂,其IC 50 值为70nM,Ki值为35nM。 | ||||
| GC10294 | Tasisulam | 519055-62-0 | >99.00% | |
An anticancer agent | ||||
| GC10334 | INH6 | 1001753-24-7 | >99.00% | |
A Hec1/Nek2 inhibitor | ||||
| GC10342 | Calpeptin | 117591-20-5 | >98.00% | |
Calpeptin是一种可逆且可穿透细胞的半胱氨酸组织蛋白酶抑制剂。Calpeptin对钙蛋白酶I和II(猪源)、木瓜蛋白酶以及血小板钙蛋白酶I的ID 50 值分别为52nM, 34nM, 138nM和20nM。Calpeptin可减轻肌肉细胞中的凋亡和继发性炎症变化。 | ||||
| GC10345 | Bay 11-7085 | 196309-76-9 | >99.00% | |
Bay 11-7085是一种NF-κB活化和IκBα磷酸化的抑制剂,对IκBα的IC 50 值为10μM。 | ||||
